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ABSTRACT: New insights into the obscure mechanisms of solid-state deracemization phenomena are obtained by crystal ripening 
experiments that, contrary to standard techniques, exclude attrition enhancement (grinding). The results point out that small parti-
cles and an initial size imbalance between the two enantiomeric crystal populations can intensify the rate of solid-state enantiomeric 
enrichment even in the absence of intermediate actions (e.g. grinding or thermal cycling). On this ground, a new process that cre-
ates such initial conditions is designed and exemplified for the proteinogenic glutamic acid. As a first step, racemic compound solv-
ate (DL-glutamic acid monohydrate) crystals are completely converted to small-sized conglomerate anhydrate crystals, in the pres-
ence of larger seeds of a single chirality. After the transformation is complete and the racemization catalyst is added, the suspension 
contains an equal number of small-sized conglomerate crystals of both enantiomers together with the larger seeds of the preferred 
enantiomer. Over time, the large crystals of the preferred enantiomer tend to grow at the expense of smaller ones, which dissolve. 
This, combined with the fast racemization, leads to enantiomeric enrichment. The possible occurrence of enantioselective agglom-
eration between small and seed crystals speeds up this process by removing small crystals of the preferred enantiomer. Since most 
amino acids and several other pharmaceutical compounds are known to form metastable racemic hydrate crystals, it is expected that 
this new method is readily applicable to a variety of compounds. In addition, the process provides a technically simpler and more 
scalable route to enantiomeric enrichment compared to attrition-enhanced deracemization and its applicability extends to the wider 
pool of compounds that crystallize as racemic crystals.
INTRODUCTION 
 
Synthesis of enantiopure compounds is a major challenge for 
the pharmaceutical and fine chemical industries 1. Among the 
various approaches to obtain single enantiomers, separation of 
racemates by means of crystallization processes is the most 
widely employed technique at large scale 2. When the race-
mate crystallizes as a mixture of enantiopure crystals (racemic 
conglomerate), near-equilibrium ripening processes combined 
with solution-phase racemization can be employed to com-
pletely convert the racemic mixture into one chirality, in a so-
called deracemization process 3. Viedma demonstrated such a 
process for the achiral NaClO3 that forms chiral conglomerate 
crystals, by using wet-milling in isothermal conditions 4. Since 
then, variants of this method, now termed as Viedma ripening 
5
, have been applied to chiral organic compounds that crystal-
lize as (metastable) conglomerates and racemize in solution 6±
18
. The method has also been combined with a reaction be-
tween achiral substrates to deliver an enantiopure product 19. 
The mechanisms of Viedma ripening are generally believed to 
include growth-dissolution due to size dependence of solubili-
ty, agglomeration, breakage and solution phase racemization 
5,9,20,21
. Besides the practical application of Viedma ripening, it 
has also been considered by some as a likely enantiomeric 
excess amplification mechanism that could possibly aid in 
unravelling the enigmatic origin of homochirality in biologi-
cally relevant molecules 22,23.  
Even though Viedma ripening is a promising method to obtain 
enantiopure compounds, it suffers from two major limitations: 
a) it is only applicable to conglomerate forming compounds 
(5-10% of chiral organic molecules); and b) scale-up is chal-
lenging, as one would have to ensure that the attrition rate 
attained at the lab scale can be transferred to larger scales and 
that the crystallizer has the mechanical properties to withstand 
the stress involved. In addition, further process steps may be 
required to separate the grinding media from the solid product. 
Current research focuses on alternative methods to intensify or 
replace grinding, such as ultrasound 24,25, or thermal treatments 
(spatial 26,27 or temporal 28±30 temperature variations). On the 
other hand, studies try to extend the process to compounds that 
form racemic crystals (mixed crystals of both enantiomers), by 
studying racemic crystal transformations to conglomerates, 
followed by grinding 12,18.  
Crystal form transformations are most often solution-mediated 
and their rate depends on the interplay between the rate of 
dissolution of the metastable phase and the nucleation and 
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growth rate of the stable phase 31,32. Furthermore, if large solu-
bility differences between the two phases exist, high supersat-
uration values can be attained, favoring crystal nucleation over 
growth leading to very small final crystal sizes 33. The link 
between crystal size and deracemization has been highlighted 
in several studies of Viedma ripening 9,25. Small mean crystal 
size and a bias in the crystal size distributions of the two enan-
tiomers are generally preferred to attain fast enantiomeric en-
richment, because: a) smaller particles tend to dissolve faster; 
therefore in the presence of fast racemization, the dissolution 
of the minor enantiomer is accelerated; and b) a larger size 
difference between the two enantiomers provides a larger 
drive for growth of the major enantiomer via Ostwald ripening 
5,21
. On this basis, we hypothesized that a swift solution-
mediated transformation of racemic crystals to conglomerates 
taking place preceding the deracemization process could sig-
nificantly reduce the mean crystal size in a suspension. If the 
method is also combined with seeding of single chirality crys-
tals, a sufficient bias in the crystal size distributions of the two 
enantiomers might ensue. The combination of small mean 
crystal size and a bias between the crystal size distributions of 
the enantiomers might effectively speed up the deracemization 
process to such extent that will allow grinding to be minimized 
or even be excluded. Importantly, such a process would extend 
the applicability of solid-state deracemization techniques from 
conglomerate forming compounds to the wider pool of chiral 
compounds that form racemic crystals. The hypothesis is test-
ed experimentally for glutamic acid, a proteinogenic amino 
acid essential to neurotransmission and metabolism 34.  
Glutamic acid is one of the few amino acids that crystallize as 
a metastable conglomerate at room temperature, although it 
can crystallize also in two racemic compounds: the DL-
glutamic acid monohydrate 35 and the anhydrous DL-glutamic 
acid 36. Glutamic acid can be efficiently racemized in acidic 
media 37 and relatively mild temperatures in the presence of 
catalytic aldehydes, via the formation of the Schiff base 38. 
Although several studies have investigated the polymorph 
transformation for glutamic acid conglomerate 39±41, very few 
have studied the racemic hydrate to conglomerate transfor-
mation. Spix et al. recently showed that in acetic acid, the ra-
cemic compound monohydrate is the least stable form and 
converts quickly to the anhydrous conglomerate, which in turn 
converts very slowly to the anhydrous racemic compound 
(most stable form) 12. The conglomerate was shown to be suf-
ficiently stable to prevent the formation of the racemic com-
pound anhydrate, even in the presence of grinding. As a result, 
in the same study, it was also shown that enantiopure glutamic 
acid can be obtained by Viedma ripening starting from a mix-
ture of conglomerate and hydrate crystals in acetic acid using 
salicylaldehyde as racemization catalyst. 
Herein, we investigate whether the use of a solution-mediated 
racemic crystal transformation prior to deracemization can be 
used to modify the initial crystal size distribution and promote 
enantiomeric enrichment without the need of intense grinding. 
To achieve this, we perform sets of chiral amplification exper-
iments without grinding for the model compound glutamic 
acid using two different initial preparation methods that start 
from different crystalline forms. Further, the transformation of 
the DL-glutamic acid monohydrate crystals to the conglomer-
ate anhydrate is studied in more detail. Finally, chiral amplifi-
cation experiments using an artificial bias in the crystal size 
distributions of the two enantiomers offer important insight 
into the mechanisms of chiral symmetry breaking in heteroge-
neous systems.     
EXPERIMENTAL SECTION 
Model system preparation prior to chiral amplification. Prior to 
the chiral amplification experiments, two preparation methods were 
applied. In both methods, a suspension of glutamic acid crystals with 
an initial enantiomeric excess of either 62.7% or 21.9% was created 
by adding 10 mL of acetic acid into a jacketed reactor vessel. Subse-
quently, the suspension was heated to 70 °C (heating period of ap-
proximately 4 minutes) using a thermostatic bath, while magnetically 
stirring at 1200 rpm and was maintained at this temperature for 30 
min. After the initial 30 min at 70 °C, the first sample (t = 0) was 
taken and the temperature was increased to 90 °C (heating period of 
approximately 2 minutes). 
Preparation method without crystal transformation (method A). In 
preparation method A, conglomerate D- and L-glutamic acid crystals 
were used to create the initial enantiomeric excess. Additionally, a 
small amount of MilliQ water (26 mg and 52 mg for enantiomeric 
excesses of 62.7% and 21.9%, respectively) was added, to ensure 
comparable conditions with method B, where the DL-glutamic acid 
hydrate transformation unavoidably results in some water being pre-
sent in the system. The total mass of the added solid together with the 
water was always kept at 600 mg.    
Preparation method with crystal transformation (method B). In 
preparation method B, DL-glutamic acid hydrate was combined with 
conglomerate L- or D-glutamic acid to create the initial enantiomeric 
excess (total mass of solid: 600 mg). At the conditions tested, DL-
glutamic acid monohydrate converts completely to the anhydrous D- 
and L-glutamic acid conglomerates as checked with XRD and also 
reported by Spix et al 12. Since for the DL-glutamic acid monohy-
drate, one mole of H2O is present for every glutamic acid molecule, 
the actual amount of solid glutamic acid after the transformation is 
slightly less than 600 mg, with some water also being released into 
the system. 
Chiral amplification experiments without grinding. After the re-
spective preparation method was applied, the chiral amplification 
experiments were initiated by adding the racemization catalyst, salic-
ylaldehyde (140 mg). All chiral amplification experiments were con-
ducted at the same conditions and only the preparation method was 
different. During these experiments, the temperature was controlled at 
90 °C for the entire duration of the experiments (maximum experi-
mental duration: 30 h) and the solid phase was regularly sampled. 
Suspension samples from different locations of the vessel (total of 
250 µL) were taken over time, vacuum filtered over a P4 glass filter 
to remove the solvent and washed using 2 mL of acetone. Prior to the 
chiral HPLC analysis, the resulting crystals were dried overnight by 
means of an oven set at 40 °C.  
Determination of the solid phase enantiomeric excess by chiral 
HPLC analysis. Prior to the analysis, the dried solid samples were 
dissolved in MilliQ water to give a solution of 1 mg/mL concentration 
of glutamic acid. Subsequently, the samples were analyzed using an 
HPLC apparatus (Agilent 1100 Series) with a Chirex 3126 column. 
D- and L-glutamic acid concentrations were measured using a Diode 
Array Detector (DAD) at 254 nm. The eluent was 2 mM CuSO4 in 
ultrapure (MilliQ) water at a flow rate of 1 mL/min and the column 
temperature was controlled at 40 °C. The injection volume was 20 
µL. The enantiomeric excess was calculated based on the detector 
response peak areas for D- and L-glutamic acid as: e.e. = |AD ± AL| / 
(AD ± AL).   
Crystal size distribution (CSD) measurement. After the end of the 
experiments, all remaining crystals were collected using vacuum 
filtration and dried, as mentioned above. The dry crystals were dis-
persed in ethanol at room temperature and were immediately subject-
ed to measurement of the Crystal Size Distribution (CSD) using a 
Malvern Mastersizer S with MS14 sample dispersion unit. Crystal 
size, shape and morphology were also checked by light microscopy 
pictures, taken using an Olympus BX41 microscope coupled with a 
Hamamatsu C4742-95 Digital Camera Controller at different magni-
fications. 
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Figure 1. Left: Evolution of solid-phase enantiomeric excess for glutamic acid crystals at 90 °C without grinding at the same con-
ditions using two different initial preparation methods (a minus sign is assigned to a D-glutamic acid enantiomeric excess). Prepara-
tion method A (black triangles): No crystal transformation takes place. Preparation method B (red squares): Experiments with an 
initial transformation of DL-glutamic acid monohydrate crystals to conglomerates in the presence of D- or L-glutamic acid seeds 
prior to chiral amplification. Right: Simplified scheme of the underlying mechanisms in the deracemization process for glutamic 
acid using preparation methods A and B. 
 
XRPD analysis for the determination of crystal form. For the 
transformation of the DL-glutamic acid hydrate crystals to the anhy-
drous conglomerates, separate experiments were done, in which 2 g of 
DL-glutamic acid hydrate were stirred at 1200 rpm in 10 mL of acetic 
acid. Temperature was increased to 70 °C and kept for 30 min. Sub-
sequently, temperature was increased to 90 °C and was kept for 24 h. 
The conditions of these experiment were similar to the chiral amplifi-
cation experiments. Samples were taken for XRPD analysis after 30 
min at 70 °C, 2h at 90 °C and 24h at 90 °C. The crystal form was 
determined by X-Ray powder diffraction (XRPD), using a Philips 
PW1830 diffractometer with Bragg/Brentano theta-2theta setup, 
&X.ĮUDGLDWLRQN9P$DQGDJUDSKLWHPRQRFKURPDWRU7KH
scan range was between 10 and 40°, a step size of 0.01 was used and 
the time/step was 2 s.    
RESULTS AND DISCUSSION 
Effect of the preparation method on chiral amplification 
without grinding. Two sets of experiments were designed to 
investigate whether chiral symmetry breaking of glutamic acid 
crystals is possible in the absence of any grinding using two 
initial preparation methods. These experiments were per-
formed at the same conditions starting from several values of 
the initial enantiomeric excess and the results are presented in 
Figure 1. In preparation method A, no crystal transformation 
takes place, while in preparation method B, the DL-glutamic 
acid monohydrate crystals fully convert to anhydrate con-
glomerate crystals 12. Furthermore, in preparation method B, 
the addition of the larger seed crystals combined with the 
change in crystal form can create a bias in the crystal size dis-
tribution of the enantiomers. When the preparation methods 
are complete (t = 0 h in Figure 1), chiral amplification experi-
ments are performed by adding the racemization catalyst to the 
prepared suspension (0h-30h in Figure 1). 
Figure 1 shows that in all experiments carried out after prepa-
ration method A (black triangles in Figure 1), increase in the 
enantiomeric excess is very slow for the times studied. As an 
example, for the experiment starting from an enantiomeric 
excess of 28%, a value of 32% is obtained after 24 hours. Pro-
longed time for this experiment did not result in a significant 
increase in the enantiomeric excess. In the absence of any 
grinding, the rate of the enantiomeric excess increase is 
strongly suppressed as it has been explained in several exper-
imental 4,25,42 and modelling 21,43 studies of Viedma ripening. 
As an example of the effect of attrition, Noorduin et al. found 
that the rate of enantiomeric excess increase was approximate-
ly 3.5-fold higher for a chiral organic compound, when the 
amount of grinding media doubled  42.        
Conversely, in every experiment carried out after preparation 
method B (red squares in Figure 1), substantial increase in the 
enantiomeric excess in time was observed in the absence of 
grinding. Indicatively, for an experiment starting from an en-
antiomeric excess of 25%, an increase to 63% was observed in 
24 hours. For a similar experiment in the study of Spix et al., 
but in the presence of grinding with glass beads, enantiomeric 
excess increased from 25% to approximately 85% in 24 hours 
12
. Considering these differences, our results indicate that en-
antiomeric enrichment is possible to occur even in the absence 
of grinding. The final chiral outcome is determined by the 
enantiomer present as the glutamic acid anhydrate seeds. The 
results obtained for D- and L-glutamic acid are symmetric 
with regard to the enantiomeric excess evolution profile, in 
accordance with previous studies 6,12.  
For the experiments carried out after preparation method B 
that start at a lower initial enantiomeric excess, the enantio-
meric excess levels off and even decreases (not shown) after 
approximately 28 hours, similarly to previous Viedma ripen-
ing results for glutamic acid 12. This effect was not observed 
when method A was used. Eventually, however, decrease in 
enantiomeric excess is expected for the experiments carried 
out after method A experiments as well, since the conglomer-
ate crystal form has been shown to be metastable and in time 
will transform into the stable anhydrous racemic compound, 
which cannot be deracemized 12. The rate of this transfor-
mation inevitably limits the time window in which enantio-
meric enrichment is possible for this system. 
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Viedma et al. have reported relatively fast enantiomeric excess 
increase in the absence of grinding for aspartic acid. In their 
study though, a heating plate was used to create a strong tem-
SHUDWXUH JUDGLHQW ZKLFK DFFRUGLQJ WR WKH DXWKRU¶V LQWHUSUHWa-
tion enhanced crystal dissolution in hot zones and crystal 
growth in cold zones, effectively leading to deracemization 26. 
Temporal temperature variations have also been shown to 
induce enantiomeric enrichment in a similar manner 28,29,44. 
However, such effects can be excluded in the present study, 
since a heating jacket was used to create a homogeneous and 
controlled temperature profile in the reactor, which remained 
essentially constant for the entire duration of the experiments. 
Partial dissolution or decomposition of a scalemic mixture of 
conglomerate crystals can also lead to an increase in the solid 
phase enantiomeric excess, even in the absence of racemiza-
tion, since such mixtures tend to dissolve with a eutectic enan-
tiomeric excess of 0%. To make sure that increase in the enan-
tiomeric excess is not only due to partial dissolution of the 
scalemic mixture at the temperature of the experiments, the 
final solid yield was determined in separate experiments start-
ing from a prepared enantiomeric excess of 62.7%. These ex-
periments were performed at the same conditions as the chiral 
amplification experiments using preparation method B and 
starting with a high initial enantiomeric excess in order to 
reach close to enantiopurity. A solid yield of  ? 78% with enan-
tiomeric excess > 97% was obtained in these experiments. The 
mass of the nearly enantiopure solid obtained in the end of the 
experiments was 452 mg ( ? 26% higher than the amount of 
seed crystals initially added), while the mass of the counter 
enantiomer was only 6 mg. This confirms that partial dissolu-
tion of the racemic mixture, although it plays a role, it is alone 
insufficient to explain the observed increase in the enantio-
meric excess. Loss of solid is mainly due to the solubility of 
glutamic acid in the solvent as reported by Spix et al. and may 
be circumvented by working at lower temperatures 12. 
The experimental results obtained highlight several aspects of 
the enantiomeric enrichment mechanism and the influence of 
the initial preparation method on its outcome. When prepara-
tion method B precedes the experiment, the rate of enantio-
meric excess increase is comparably fast to processes conduct-
ed under enhanced attrition, i.e. using glass beads in combina-
tion with stirring. At the same time, when method A precedes 
the experiment, enantiomeric excess hardly increases. The 
seemingly faster rate obtained using method B versus method 
A at the same conditions is in accordance to our initial hy-
pothesis that in the presence of seeds, a solution-mediated 
transformation of racemic crystals to conglomerates affects the 
initial crystal size distribution to such extent that ultimately 
enables enantiomeric enrichment. 
Evolution of crystal size during the chiral amplification 
process. Figure 2 presents the initial (before preparation) and 
final (after both preparation and chiral amplification) crystal 
size distributions for an experiment conducted after using 
preparation method A. The final volume- and number-based 
crystal size distributions, measured after the end of this exper-
iment, appear to be very similar to the initial ones, indicating 
that crystal attrition, e.g. due to magnetic stirring, is quite re-
stricted at the experimental conditions tested. The mean crys-
tal size of the conglomerate L- and D-glutamic acid crystals, 
initially used to start this experiment, is measured at d4,3 = 187 ȝPand d1,0 ȝP7KHFRPPHUFLDO'- and L-glutamic acid 
conglomerate crystals, which were used initially have very 
similar crystal size distributions (Figure 2 blue line and Figure 
3 blue line); thus there is no significant bias to one enantiomer 
due to differences in crystal size, as it has been shown to be 
possible in another work 8. After 30 hours only a slight de-
crease in the mean crystal size is observed, measured at d4,3 = ȝPDQGd1,0 ȝP7KHVPDOOGHFUHDVHLQcrystal size is 
attributed to the partial dissolution of the crystals due to the 
initial temperature increase and to some inevitable (minor) 
breakage occurring due to crystal collisions in the mixed sus-
pension. 
Figure 3 presents the initial (before preparation) and final (af-
ter both preparation and chiral amplification) crystal  size dis-
tributions for an experiment carried out after using preparation 
method B. The initial size distribution reported is that of the 
added conglomerate seeds of L- glutamic acid (without the 
hydrate) in order to allow for size comparison of the same 
crystal type since the final solid mixture contains only the 
conglomerate. It is found that the crystal size distribution 
shifts towards a smaller final size range when method B is 
used, with the final mean crystal size being d4,3  ȝPDQG
d1,0  ȝPA considerable number of smaller particles is 
detected at the end of the process, ranging from a size of 0.5 to 
5 µm. 
The observed evolution of crystal size using preparation meth-
od B and subsequent chiral amplification bears a strong re-
semblance to attrition-enhanced deracemization experiments 
reported in the literature 5,9. In such experiments, the mean 
crystal size rapidly decreases and the crystal size distribution 
broadens, as new smaller particles emerge at different sizes 
due to the breakage of larger ones. Similarly, using prepara-
tion method B, mean particle size is reduced and crystal size 
distribution broadens, not due to breakage, but due to the for-
mation of new smaller particles. On the contrary, when using 
preparation method A, crystal size only slightly decreases and 
no significant increase in the enantiomeric excess is observed. 
Since in preparation method B, the transformation of the DL-
glutamic acid monohydrate crystals to the L- and D-glutamic 
acid anhydrous conglomerates takes place, we hypothesized 
that the emergence of the small particles is a result of the 
transformation. 
DL-glutamic acid monohydrate transformation. In order to 
investigate the transformation, a new experiment was designed 
at similar conditions to those of preparation method B and the 
subsequent chiral amplification experiments, this time starting 
only from the DL-glutamic acid hydrate crystals in the ab-
sence of any racemization catalyst. The resulting crystals were 
analyzed using X-ray powder diffraction (XRPD), optical mi-
croscopy and laser diffraction. Figure 4 presents the XRPD 
patterns of several samples extracted at different times during 
this experiment. It appears that already after 30 min under 
stirring at 70 °C, the hydrate fully dissolved, while the con-
glomerate formed. This finding confirms that in all chiral am-
plification experiments preceded by preparation method B, 
crystal transformation is complete prior to the start of the en-
antiomeric enrichment process. The fast transformation of the 
DL-glutamic acid crystals at elevated temperatures mostly acts 
to supply the mixture with the D and L conglomerates required 
for the chiral amplification experiments. Figure 4 also shows 
that the conglomerate structure is preserved at 90 °C up to 24 
h, which is most of the duration of the chiral amplification 
experiments. It is noted that for the same transformation ex-
periment at room temperature, XRPD analysis revealed a mix-
ture of the hydrate and the conglomerate for more than 3 
hours, after which the experiment was terminated. 
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Figure 2. Evolution of number- (left) and volume-based (right) crystal size distribution (CSD) measurements (%) by laser diffrac-
tion for a 30-hour chiral amplification experiment after using preparation method A. Initial CSD is that of the mixture of L- and D-
glutamic acid crystals added prior to the preparation. Final CSD is the one measured after both preparation and chiral amplification 
experiment.  
 
 
Figure 3. Evolution of number- (left) and volume- based (right) crystal size distribution (CSD) measurements (%) by laser diffrac-
tion for a 30-hour chiral amplification experiment after using preparation method B. Initial CSD is that of the conglomerate L-
glutamic acid crystals added prior to the preparation(20 wt% of the solid phase). Final CSD is the one measured after both prepara-
tion and chiral amplification experiment.  
 
Analysis of the solid phase enantiomeric excess of the same 
samples (30 min, 2 h and 24 h) revealed that the composition 
remained racemic throughout the crystal transformation pro-
cess. Therefore, phenomena of preferential enrichment due to 
crystal transformation can also be excluded 45,46.  
Figure 5 presents optical microscope images of the newly 
formed conglomerate crystals for the same experiment and 
over the same time intervals. After 30 min at 70 °C, no mono-
hydrate crystals are visible and the conglomerate crystal size is 
significantly smaller compared to that of the initial hydrate 
crystals. The mean crystal size after 30 min is measured by 
laser diffraction at d4,3  ȝPDQGd1,0 ȝPVLPLODUWRWKH
final mean crystal size obtained in the chiral amplification 
experiments preceded by preparation method B. Additionally, 
the crystal size distribution is quite broad, with several crystals 
at sizes between 1- ȝP&U\VWDOVL]HVHHPVWRGHFUHDVHHYHQ
further after 2h and at 90 °C due to some partial dissolution of 
the crystals at the higher temperature (Figure 5).  
Figure 6 presents in-situ microscope pictures of an experiment 
using a temperature-controlled cell at 70 °C showing the con-
version of the hydrate crystals in the presence of conglomerate 
seeds at stagnant conditions. It shows that at the early stages of 
the re-crystallization process, liquid-liquid phase separation 
might occur, which possibly facilitates the formation of the 
conglomerate crystals (more information is provided in the 
Supporting Information). During the fast transformation pro-
cess, the size of the initial seed population remains roughly 
unchanged, although they seem to grow very slowly. 
The information provided in this section explains the strong 
effect of the preparation method B on the evolution of the 
enantiomeric excess in the absence of attrition enhancement. 
Preparation method B starts with a mixture of two crystal pop-
ulations at 70 °C: a) the DL-glutamic acid monohydrate crys-
tals and b) the L- or D-glutamic acid conglomerate seed crys-
tals. At these conditions, the whole DL-glutamic acid mono-
hydrate crystal population swiftly dissolves, leading to high 
concentration of glutamic acid molecules in the solution 
phase. Subsequently, the concentration decreases by the fast 
crystallization of the conglomerate D- and L-glutamic acid 
crystals. 
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Figure 4. XRPD patterns of samples taken after stirring a DL-
glutamic acid monohydrate (blue) suspension in acetic acid 
for: a) 0.5 h at 70 °C (orange); b) 2 h at 90 °C (grey); c) 24 h 
at 90 °C (green); d) pure conglomerate (yellow). 
 
 
 
Figure 5. Optical microscope images (room temperature) of 
the newly formed conglomerate crystals, due to the transfor-
mation of the DL-glutamic acid monohydrate crystals (upper 
left) in acetic acid with stirring, after 0.5 h at 70 °C, 2 h at 90 
&DQGKDW&:KLWHEDUFRUUHVSRQGVWRȝP,QWKH
lower right picture, a magnification is provided (white bar is 
ȝPLQWKDWSLFWXUH Dry crystals were suspended in antisol-
vent (ethanol) before taking the images. 
 
The newly formed population of D- and L-glutamic acid con-
glomerate crystals is overall racemic and has a significantly 
lower mean crystal size compared to the initial conglomerate 
seeds. During this process, the size of the homochiral large 
seeds does not change significantly, as most of the supersatu-
ration is consumed during the nucleation and growth of the 
large number of new small conglomerate crystals (Figure 6). 
Thus, the net result is a strong decrease in the overall mean 
particle size and the generation of a biased CSD: the counter 
enantiomer is only present as small sized-crystals, while the 
preferred enantiomer is present as both small-sized crystals 
and large seed crystals. 
 
Figure 6. Early stage microscope pictures (every 30 seconds) 
of the DL-glutamic acid hydrate crystal transformation in the 
presence of already existing larger conglomerate seeds (70 °C 
in acetic acid, stagnant conditions). Conglomerate crystals are 
not dissolving at the experimental conditions; instead they 
seem to grow slightly. The crystal transformation seems to 
progress by liquid-liquid phase separation. 
 
Due to the absence of the racemization catalyst, no significant 
increase in the enantiomeric excess has occurred yet (t=0 h in 
Figure 1). Subsequently, temperature is increased to 90 °C. It 
is noted that some increase in the enantiomeric excess pertains 
also to the increased solubility at the higher temperature lead-
ing to partial dissolution of the scalemic mixture.    
After the preparation method and the equilibration of the sys-
tem is at 90 °C, the racemization catalyst is added. The addi-
tion of the catalyst marks the start of the chiral amplification 
process. During the actual experiment i.e. the ripening period, 
the system remains at constant temperature near equilibrium. 
At these conditions, the largest crystals (present only as the 
preferred enantiomer) will tend to grow at the expense of the 
small ones of both chiralities that dissolve, so that the total 
surface area and surface energy of the system are reduced. The 
aforementioned process combined with the racemization reac-
tion, leads to an enrichment of the solid phase towards the 
preferred enantiomer. The possible occurrence of enantiose-
lective agglomeration of small and seed crystals would speed 
up this process by removing small crystals of the preferred 
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enantiomer from the process. Since the minor enantiomer is 
only present as small crystals, it may eventually fully dissolve 
and racemize. Attrition enhancement may not be needed in 
this process because preparation method B creates suitable 
initial conditions for fast chiral ripening. A schematic repre-
sentation of the underlying mechanisms in method B is illus-
trated in Figure 7. 
Chiral amplification experiments in the absence of the 
crystal transformation. The evidence provided in the previ-
ous section strongly suggests that the enhanced rate of in-
crease in enantiomeric excess without attrition, obtained using 
the combined DL-glutamic acid monohydrate conversion to 
conglomerate (preparation method B) and subsequent ripen-
ing, is a result of the differences in the crystal size distribu-
tions of the two enantiomers, artificially engineered by the 
addition of seeds. In preparation method B, the transformation 
of the hydrate crystals took place in the presence of enanti-
opure seeds. Under such conditions, the seeds could grow or 
induce secondary nucleation and consume the supersaturation 
generated by the dissolution of the more soluble hydrate crys-
tals. Since slow racemization of amino acids is possible also in 
acetic acid without any catalyst, such an effect could also lead 
to gradual increase in the enantiomeric excess. 
 
 
Figure 7. Schematic representation of the influence of an ini-
tial racemic crystal transformation to conglomerate (prepara-
tion method B) on the enantiomeric enrichment process.  
In order to prove that the crystal size difference rather than the 
dissolution of the hydrate and direct growth of the seeds drives 
the evolution of the enantiomeric excess, we designed a new 
experiment, in which the seeds are not present during the crys-
tal transformation. In this experiment, we first re-crystallized 
the DL-glutamic acid monohydrate crystals in ethanol, under 
stirring for 1 hour at 60 °C, in order to obtain the conglomer-
ate. The resulting crystals were filtered, dried and subjected to 
XRPD analysis, laser diffraction and measurement of the solid 
phase enantiomeric excess (see Supporting Information). The 
XRPD analysis revealed that the resulting crystals were indeed 
the conglomerate, with no trace of the hydrate. The mean crys-
tal size of the newly formed conglomerate crystals was meas-
ured at d4,3  ȝPDQGd1,0 ȝPDQGWKHVROLGSKDVH
enantiomeric excess was determined to be 0% by means of 
chiral HPLC. 
Subsequently, the newly formed conglomerate crystals were 
directly used in chiral amplification experiments combined 
with larger L or D conglomerate seed crystals to create size 
imbalance. Note that in these experiments no further prepara-
tion took place.  
 
 
 
Figure 8. Evolution of solid-phase enantiomeric excess for 
glutamic acid crystals at 90 °C without attrition enhancement, 
at the same conditions. Black triangles: preparation method in 
the absence of seeds. Red squares: preparation method in the 
presence of seeds (method B). 
 
Figure 8 displays the temporal evolution of the solid phase 
enantiomeric excess for the new experiments, in comparison 
with experiments carried out after preparation method B at the 
same conditions. In all new experiments, an increase in the 
enantiomeric excess is observed (black triangles in Figure 8) 
with time. The enantiomeric excess evolution profile is very 
similar to the one obtained after using preparation method B 
(red squares in Figure 8), which suggests that indeed the dif-
ference in the size distributions of the two enantiomers is the 
dominant factor influencing the enantiomeric enrichment pro-
cess.  
Iggland & Mazzotti in a recent computational study consid-
ered cases where growth and dissolution due to crystal size 
differences coupled with racemization alone can lead to enan-
tiopurity in the absence of attrition 47. They exemplified that 
IRUWKLV³FKLUDOULSHQLQJ´WRWDNHSODFHDPDVVLPEDODQFHLVQRW
sufficient and a difference in the size distribution between the 
two enantiomers is needed. According to their analysis, this 
XQFRQYHQWLRQDO ULSHQLQJ SURFHVV LV GLVWLQFW IURP WKH ³FODVVi-
FDO´ 9LHGPD ULSHQLQJ ZKHUH DWWULWLRQ DQG DJJORPHUDWLRQ DUH
thought to play an important role. The process described in the 
present work is DQH[DPSOHRIVXFK³FKLUDOULSHQLQJ´ZLWKRXW
attrition, although the extent to which agglomeration is in-
volved is not yet clear. Importantly, the results suggest that 
intermediate actions (e.g. grinding or thermal cycling) may be 
minimized, while still maintaining a fast rate of enantiomeric 
enrichment as long as the initial conditions for the two enanti-
omeric crystal populations are carefully tuned (small crystals, 
broad crystal size distribution, large difference in size between 
enantiomers). 
CONCLUSIONS 
This study demonstrates that isothermal ripening of crystal 
suspensions in racemizing conditions can, under certain initial 
conditions, lead to fast solid phase enantiomeric enrichment, 
even in the absence of attrition enhancement (grinding). Ap-
propriate initial conditions are: a) large number of small parti-
cles and b) sufficient size imbalance between the CSDs of the 
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two enantiomer crystals. For the examined case of glutamic 
acid, such conditions are created by the fast and complete so-
lution-mediated transformation of DL-glutamic acid monohy-
drate crystals to small sized anhydrous conglomerates in the 
presence of larger homochiral seeds. After the transformation 
is complete and the racemization catalyst is added, the system 
contains a newly formed racemic population of small con-
glomerate crystals together with larger homochiral seed crys-
tals of the preferred enantiomer. Under such conditions, the 
large crystals of the preferred enantiomer tend to grow at the 
expense of small crystals, which dissolve. This, combined 
with the fast racemization, leads to enantiomeric enrichment. 
The process might be further accelerated due to the possible 
enantioselective agglomeration of small and seed crystals of 
the preferred enantiomer. Attrition enhancement is not needed 
in this process as the initial conditions allow for fast chiral 
ripening. This is further confirmed by additional experiments 
that exclude the in-situ transformation and start directly from a 
mixture of conglomerate crystals of both chiralities with an 
artificial size imbalance. A similar rate of enantiomeric en-
richment is found in these experiments. Overall, the proposed 
method provides a practical and scalable route to enantiomeric 
enrichment, by minimizing the use of grinding media and in-
tense attrition conditions. Equally important, the process is 
applicable to the wider pool of chiral organic compounds that 
crystallize as racemic crystals and undergo similar crystal 
transformations. However, more studies are required to opti-
mize this process and to allow reaching enantiopurity starting 
from lower initial enantiomeric excess values by increasing 
the deracemization rate and suppressing the formation of sta-
ble racemic compounds. Finally, the enantiomeric excess am-
plification mechanism reported here, at relatively mild tem-
peratures and in the absence of grinding, might provide a like-
ly mechanism for the origin of homochirality in amino acids 
that are present in biologically relevant molecules. 
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Synopsis: A solution-mediated transformation of racemic compound solvate crystals to conglomerates can intensify the rate of 
solid-state deracemization during subsequent isothermal ripening experiments, even without intermediate actions (i.e. grinding or 
thermal cycling). This effect may lead to the development of practical and scalable processes for enantiomeric enrichment of com-
pounds that form metastable racemic crystals and can undergo such transformations. 
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Initially, in order to validate whether a transformation of the DL<glutamic acid monohydrate 
crystals indeed takes place, experiments were done using in<situ optical microscopy. Figure S1 
tracks visually the evolution of the solid phase in acetic acid at 70 °C in a temperature<controlled 
cell. Within 100 s the hydrate crystals dissolve completely and almost instantly a new phase 
nucleates and starts to grow. Liquid<liquid phase separation (LLPS) seems to occur shortly after 
the dissolution of the hydrate crystals at regions where the glutamic acid concentration is high 
enough. It is mentioned that the conditions of this experiment are not directly comparable with 
the conditions of the chiral amplification experiments and were done only to validate whether a 
crystal transformation indeed takes place. The newly generated particles seem to follow a 
polycrystalline growth pattern (spherulitic growth) as it is shown clearly in Figure S2. Spherulitic 
growth pattern has been observed before during the precipitation of L<glutamic acid under highly 
supersaturated conditions 
2
. At high supersaturations, it has been proposed by Roelands et al. that 
the spheres are essentially a metastable phase consisting of droplets formed by liquid<liquid 
phase separation and serve as precursors to the formation of the stable beta form of the 
conglomerate 
2
. In our experiment, high supersaturation is generated due to the significantly 
higher solubility of the DL<glutamic acid monohydrate crystals compared to the anhydrous 
conglomerate crystals. In water and at 60 °C, DL<glutamic acid monohydrate has approximately 
7 times higher solubility than the pure conglomerate (ϐ) L<glutamic acid 
3
. Unfortunately, no 
 2
solubility data of glutamic acid in acetic acid are are available in the literature and the 
experimental solubility determination proves difficult, especially for the  DL<glutamic acid 
monohydrate, due to the fast crystal transformation. 
 
&	 '( In<situ light microscopy pictures of the DL<glutamic acid hydrate crystal 
transformation at 70 °C in acetic acid at stagnant conditions, using a temperature controlled cell. 
The swift dissolution of the hydrate crystals and the re<crystallization of a new solid phase is 
clearly observed. 
 
&	)( Microscope pictures of the new solid phase obtained after the transformation of the 
DL<glutamic acid hydrate crystals. The new particles strongly resemble a spherulitic structure. 
!%

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	
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To obtain a small<sized conglomerate crystal population of glutamic acid, DL<glutamic acid 
hydrate crystals were re<crystallized in ethanol at 60 °C for 1 hour. The resulting crystals were 
characterized before their use in the chiral amplification experiments. The XRPD patterns 
 3
recorded (Figure S3) confirm that the DL<glutamic acid transformation to the conglomerate is 
successful at these conditions. The volume< and number<based crystal size distributions were also 
measured and are reported in Figure S4. The mean crystal size of the newly formed conglomerate 
crystals after extracting them from the mother liquor and drying is measured at d4,3 = 74.9 µm 
and d1,0 = 3.98 µm, approximately 3 times less than the mean crystal size of the conglomerate 
seeds. Optical microscope pictures of the conglomerate crystals formed by re<crystallizing DL<
glutamic acid monohydrate crystals in ethanol are presented in Figure S5.    
 
&	 *(XRPD patterns of DL<glutamic acid monohydrate (blue), after re<crystallization in 
ethanol at 60 °C for 1 h (orange) and conglomerate reference obtained from Cambridge 
Crystallographic Structure Database (gray). The hydrate crystals convert fully to conglomerates 
after 1h in ethanol at 60 °C. 
 
&	+( Crystal size distribution measurements of the racemic conglomerate crystals obtained 
by re<crystallization of DL<glutamic acid monohydrate crystals in ethanol at 60 °C for 1 hour. 
The average crystal size is measured at d4,3 = 74.9 µm and d1,0 = 3.98 µm. 
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&	,(Microscope image of the resulting crystals after re<crystallization of the DL<glutamic 
acid monohydrate crystals in ethanol at 60 °C for 1 h. 
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